Orlen shareholders withhold discharge to Daniel Obajtek

Shareholders of Orlen have decided not to grant discharge to Daniel Obajtek and other members of the previous management board, potentially paving the way for lawsuits seeking compensation for mismanagement. Over 90% of shareholders supported withholding discharge during the annual general meeting.

This decision may also lead to financial consequences, possibly denying substantial bonuses to Obajtek and other board members. The meeting also covered dividend distribution and approved a dividend of PLN 4.15 per share for 2023. Legal challenges against the decision not to grant discharge have been noted, reflecting shareholders' dissatisfaction and potential legal ramifications for the implicated managers.